Image 1
Morphine Sulfate Tablet, Film Coated, Extended Release
Product Images NDC 0228-4271
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Morphine Sulfate (NDC 0228-4271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 10
Image 11
Image 12
This is a description of Morphine Sulfate Extended-Release Tablets by Teva with NDC 0228-4270-11. Each tablet contains Morphine Sulfate USP, and the usual dosage information should be obtained from the accompanying prescribing information. The pharmacist is advised to disperse the Medication Guide to each patient. The tablets must be swallowed whole and not crushed, broken, dissolved, or chewed. The tablets are Rxonly and come in a size of 100 tablets. The medication is controlled and must be kept out of the reach of children. The packaging also includes a GTIN code and a lot number.*
Image 13
This is a medication description for Morphine Sulfate Extended-release Tablets 30mg. It includes prescription information for pharmacists, directions for use, and dosage information. The medication guide is instructed to be dispersed to each patient with the prescription. The medication should not be crushed, dissolved, bitten or broken. Each Extended Release Tablet contains Morphine Sulfate USP 50mg, and is dispensed in a tight, child-resistant container. The dosage information should be read in conjunction with the prescribing information. The medication should be kept out of reach of children. The provided NDC code is 0228-4271-11.*
Image 14
This is a medication guide for Morphine Sulfate Extended Release Tablets. The pharmacist should distribute a medication guide to each patient. The tablets should be swallowed whole, and not broken, crushed, dissolved, or chewed. It is important to keep the medication out of reach of children. The document also includes product information such as dosage and storage requirements. The expiration date is not available.*
Image 15
This is a description of a medication with the NDC code 0228-4323-11, which is an extended-release tablet of morphine sulfate in 100mg strength. The medication comes with an accompanying medication guide and must be dispensed in a tightly sealed, light-resistant container. The medication should only be used by opioid-tolerant persons and individuals who have a valid prescription. The manufacturer is Teva, and the product code is 52-0134.*
Image 16
This is a medication called Morphine Sulfate in an extended-release tablet form. The medication should only be dispensed to opioid-tolerant patients. Each tablet contains 200mg of Morphine Sulfate. The pharmacist should provide a Medication Guide along with the medication to the patient. The tablets should be swallowed whole and not to chew, dissolve, break, or crush. The label also shows some product codes such as NDC and GTIN. The medication was manufactured by Teva Pharmaceuticals.*
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
Image 8
Image 9
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
